CARDOZA GEORGE 4
4 · SOPHiA GENETICS SA · Filed Jul 7, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CFO George Cardoza Sells 1,592 Shares
What Happened
George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA (SOPH), sold 1,592 shares in an open-market transaction on July 6, 2026. The reported weighted average sale price was $5.29 per share (range $4.97–$5.43), for proceeds of approximately $8,419. The sale was made to satisfy tax withholding obligations arising from restricted stock units that vested on July 2, 2026.
Key Details
- Transaction date: 2026-07-06 (reported on Form 4 filed 2026-07-07) — appears timely.
- Shares sold: 1,592; weighted average price: $5.29; price range: $4.97–$5.43. Total proceeds ≈ $8,419.
- Shares owned after transaction: Not disclosed in the provided filing.
- Footnotes: Sale executed pursuant to a pre-established Rule 10b5-1(c) trading plan and done to satisfy tax withholding on RSU vesting (non-discretionary). The filer can provide a breakdown of shares sold at each price within the stated range upon request.
Context
This was a routine, tax-withholding sale tied to RSU vesting and executed under a 10b5-1 plan, which is common and generally less informative about an insider’s view of the company than open-market purchases. The weighted-average price reflects multiple executions during the same day.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-07-06$5.29/sh−1,592$8,419→ 309,092 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on July 2, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.97 to $5.43, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.